Purchase Order 75N91021P00272
Award Date
3/13/21
Potential Completion Date
3/22/24
Potential Value
$101K
Federal Agency
National Cancer Institute
Awardee
Becton, Dickinson And Company
Ultimate Awardee
Becton, Dickinson & Co
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20892, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This firm fixed-price purchase order contract was awarded by the National Cancer Institute (NCI) to Becton, Dickinson and Company (BD) for maintenance services on various government-owned BD flow cytometry equipment. The $1,994,840.77 contract has a period of performance through July 1, 2026. No set-aside designation was used. BD, a global medical technology company, has extensive experience providing specialized equipment and consumables to support biomedical research and clinical programs...
This contract award to Becton, Dickinson and Company (BD) was made by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). The $549,698.74 firm fixed-price purchase order is for the FACSymphony flow cytometer and associated components, including lasers, detectors, and consumables, to support biomedical research programs at NIH facilities. The award was made through simplified acquisition...
This federal contract award is for a service maintenance agreement from the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to Becton, Dickinson and Company (BD) for the maintenance of a BD FACSCalibur flow cytometry cell analyzer and a FACSAria II cell sorter. The one-year base period has four optional one-year renewal periods, with a total potential value of $187,482.00. The contract is a firm fixed-price delivery order and does not have a set-aside...
This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Becton, Dickinson and Company (BD) for a maintenance agreement covering a BD LSR II flow cytometer with lasers and computer. The contract has a ceiling value of $20,628 and a completion date of November 17, 2014. BD is a global medical technology company that provides instruments, reagents, and services for biomedical research...
This is a firm-fixed price delivery order awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to Becton, Dickinson and Company (BD) for $5,509.79. The delivery order is for flow cytometric analysis of benign and malignant tumors. BD is a global medical technology company that provides a wide range of products and services to government agencies, including instrumentation, reagents, and services for biomedical research and clinical applications....
The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $234,947.40 firm-fixed-price purchase order to Becton, Dickinson And Company (BD) for maintenance services on a government-owned BD FACSymphony A5 flow cytometer and associated instrumentation in support of the Vaccine Branch Cytometry Core. This is a 5-year contract with a period of performance from April 1, 2022 through March 31, 2027. No set-aside was used for this commercial item...
The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $213,364.20 firm-fixed-price purchase order to Becton, Dickinson And Company (BD) for service and maintenance of a BD FACSymphony A3 flow cytometer located in San Jose, California. The contract has a completion date of February 29, 2024 and was awarded on February 26, 2019. The contract was not set aside for a specific business type. BD, a global medical technology company, provides a...
This is a $750,000.00 firm fixed price purchase order contract awarded by the National Cancer Institute to Becton, Dickinson & Co (BD) for a special order BD Biosciences LSRFortessa X-30 flow cytometer. The contract has no set-aside designation. BD is a manufacturer and supplier of medical devices, instruments, reagents, and related products to healthcare institutions, clinical laboratories, pharmaceutical companies, and the general public. BD has received numerous federal contract awards as...
This is a $86,575.68 firm fixed-price purchase order awarded by the National Institute on Aging (NIA), a component of the National Institutes of Health (NIH), to Becton, Dickinson and Company (BD) for service and maintenance on a BD A1 Symphony flow cytometry instrument. The contract has a term of approximately 4 years, with a completion date of June 12, 2028. BD, through its BDB Division and BD Biosciences brand, is a global medical technology company that specializes in flow cytometry and...
This is a firm fixed-price purchase order awarded by the National Institutes of Health's National Institute of Allergy and Infectious Diseases (NIAID) to Becton, Dickinson and Company (BD), a global medical technology company, for a one-year maintenance agreement on BD Biosciences equipment (FACSCALIBUR, FACSARIA II, LSRFORTESSA and lasers). The potential value of the order is $141,246.48. The contract does not have a set-aside designation. BD Biosciences, a division of BD, provides instruments,...